Tatyana Yu. Dubskaya

Tatyana Yu. Dubskaya

Auto-generated profile, based on publicly available information

Tatyana Yu. Dubskaya

Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2008 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
LEL. A. Ermolaeva
L. A. Ermolaeva
TDT. Yu. Dubskaya
T. Yu. Dubskaya
TFT. I. Fomina
T. I. Fomina
TVT. V. Vetoshkina
T. V. Vetoshkina
VGV. E. Gol’dBerg
V. E. Gol’dBerg

1 September 2009 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
GKG. V. Karpova
G. V. Karpova
TFT. I. Fomina
T. I. Fomina
TVT. V. Vetoshkina
T. V. Vetoshkina
TDT. Yu. Dubskaya
T. Yu. Dubskaya
OVO. L. Voronova
O. L. Voronova
APA. V. Perova
A. V. Perova

1 January 2007 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
EGE. D. Gol’dberg
E. D. Gol’dberg
ADA. M. Dygai
A. M. Dygai
VZV. V. Zhdanov
V. V. Zhdanov
TVT. V. Vetoshkina
T. V. Vetoshkina
LGL. A. Gur’yantseva
L. A. Gur’yantseva
TKT. Yu. Khrichkova
T. Yu. Khrichkova

1 March 1995 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
EGE. D. Gol'Dberg
E. D. Gol'Dberg
TBT. G. Borovskaya
T. G. Borovskaya
TFT. I. Fomina
T. I. Fomina
MFM. V. Filippova
M. V. Filippova
MSM. G. Skorokhodova
M. G. Skorokhodova
TDT. Yu. Dubskaya
T. Yu. Dubskaya

1 January 2024 in Vestnik SurGU. Meditsina
Verified
Journal Article
Closed access
EWElena Werby
Elena Werby
MFMaria Filonova
Maria Filonova
TDT. Yu. Dubskaya
T. Yu. Dubskaya
TVT. V. Vetoshkina
T. V. Vetoshkina
LSL. A. Sandrikina
L. A. Sandrikina
ACAlexey Churin
Alexey Churin
The aim is to evaluate the state of hemostasis and liver system, as well as nitrogen and protein metabolism on the model of direct lung damage in the experiment on 50 mongrel female SD rats weighing 200-250 g. In the experiment, acute respiratory distress syndrome was modeled by a single intratracheal injection of acidine-pepsin with pH-1.2 in the amount of 0.1 ml per animal in the control group (n = 25) and the modeling group (n = 25). Researchers sampled the material after 1, 3, 5, 7, and 14 days (terminal points). Lung damage was assessed by light microscopy on histological preparations. Researchers analyzed serum for biochemical studies, collecting samples from the heart in tubes containing 3.8% sodium citrate at a ratio of 1:9 for coagulation tests in tubes with activator. During the experiment, haemostasis system disturbances accompanied acute respiratory distress syndrome formation, resulting in reduced prothrombin and activated partial thromboplastin time, elevated fibrinogen concentration, and decreased antithrombin III levels. Moreover, it led to the development of multi-organ failure, as evidenced by the recorded deviations of biochemical and coagulation parameters. The combination of multiple pathological processes within a syndrome is the greatest challenge in the treatment process. The development of experimental models to identify the interrelationship of the largest number of significant systems will allow the creation of an optimal model reproducing the entire symptom complex for the development of new protocols to treat acute respiratory distress syndrome.

1 February 2011 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
ADA. M. Dygai
A. M. Dygai
VZV. V. Zhdanov
V. V. Zhdanov
GZG. N. Zyuz’kov
G. N. Zyuz’kov
LSL. A. Stavrova
L. A. Stavrova
ESE. V. Simanina
E. V. Simanina
LEL. A. Ermolaeva
L. A. Ermolaeva